A. Friedman

发表

The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders

P. Gibson, M. Sparrow, A. Friedman, 2014, International journal of rheumatic diseases.

Radiological targets in inflammatory bowel disease: An evolving paradigm

A. Friedman, 2021, Journal of gastroenterology and hepatology.

Use and abuse of faecal occult blood tests in an acute hospital inpatient setting

P. Gibson, A. Friedman, G. Hammerschlag, 2010, Internal medicine journal.

Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease

Stuart A. Taylor, R. Bryant, B. Feagan, 2021, Alimentary pharmacology & therapeutics.

The role of thiopurine metabolite monitoring in

M. Sparrow, A. Friedman, L. Beswick, 2014 .

The role of thiopurine metabolite monitoring in inflammatory bowel disease

M. Sparrow, A. Friedman, L. Beswick, 2014, Expert review of gastroenterology & hepatology.

The failure of gastroenterologists to apply intestinal ultrasound in inflammatory bowel disease in the Asia‐Pacific: A need for action

P. Gibson, Mamoru Watanabe, T. Kucharzik, 2015, Journal of gastroenterology and hepatology.

Effect of point‐of‐care gastrointestinal ultrasound on decision‐making and management in inflammatory bowel disease

P. Gibson, S. Knowles, A. Friedman, 2021, Alimentary pharmacology & therapeutics.

Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease

P. Gibson, K. Taylor, M. Sparrow, 2020, Alimentary pharmacology & therapeutics.

Early sonographic response to a new medical therapy is associated with future treatment response or failure in patients with inflammatory bowel disease

P. Gibson, K. Taylor, A. Friedman, 2022, European journal of gastroenterology & hepatology.

Systematic review: Clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis.

R. Gibson, P. Gibson, K. Taylor, 2020, Journal of Crohn's & colitis.

Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)

S. Hanauer, P. Bampton, J. Reynolds, 2018, Alimentary pharmacology & therapeutics.

P609 A treat-to-target approach via a virtual clinic amongst inflammatory bowel disease patients with secondary loss of response to anti-TNF therapy improves clinical outcomes.

K. Taylor, M. Sparrow, M. Ward, 2017, Journal of Crohn's & colitis.

Effects of fiber intake on intestinal pH, transit, and predicted oral mesalamine delivery in patients with ulcerative colitis

C. K. Yao, P. Gibson, J. Muir, 2020, Journal of gastroenterology and hepatology.

Thiopurines: Azathioprine, Mercaptopurine, and Thioguanine

P. Gibson, M. Sparrow, A. Friedman, 2016 .

Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application

P. Gibson, R. Bryant, K. Taylor, 2018, Gut.

Nonspecific ileitis: Impact of histopathology and gastrointestinal ultrasound in achieving the diagnosis of Crohn's disease

P. Gibson, K. Taylor, A. Friedman, 2022, JGH open : an open access journal of gastroenterology and hepatology.

Why thiopurine metabolites are relevant

A. Friedman, M. P. Sparrow, P. Gibson, 2012, Alimentary pharmacology & therapeutics.

Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease.

M. Sparrow, D. V. van Langenberg, A. Friedman, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Accuracy of gastrointestinal ultrasound and calprotectin in the assessment of inflammation and its location in patients with an ileoanal pouch.

P. Gibson, P. De Cruz, M. Sparrow, 2021, Journal of Crohn's & colitis.

Editorial: an argument for low‐dose thiopurine allopurinol combination use as first‐line therapy in inflammatory bowel disease—authors’ reply

M. Sparrow, A. Friedman, 2018, Alimentary pharmacology & therapeutics.

Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis)

P. Gibson, A. Friedman, Gerard E. Mullin, 2020, Textbook of Natural Medicine.

Accuracy and cost of diagnostic strategies for patients with suspected Crohn's disease.

P. Duca, G. Maconi, A. Friedman, 2014, Journal of Crohn's & colitis.

Interrater reliability of the assessment of disease activity by gastrointestinal ultrasound in a prospective cohort of patients with inflammatory bowel disease

P. Gibson, K. Taylor, A. Friedman, 2021, European journal of gastroenterology & hepatology.

Response to Clarke K, Regueiro M. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission. Inflamm Bowel Dis 2011 [Epub ahead of print].

M. Sparrow, A. Friedman, 2011, Inflammatory bowel diseases.

Early Assessment With Gastrointestinal Ultrasound in Patients Hospitalised for a Flare of Ulcerative Colitis and Predicting the Need for Salvage Therapy: A Pilot Study.

P. Gibson, K. Taylor, A. Friedman, 2021, Ultrasound in medicine & biology.

Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.

Rajvinder Singh, S. Connor, A. Zekry, 2017, Gastrointestinal endoscopy.

A rapid infusion protocol is safe for total dose iron polymaltose: time for change

A. Friedman, M. Garg, G. Morrison, 2011, Internal medicine journal.

P139 The learning curve of intestinal ultrasonography in assessing inflammatory bowel disease – preliminary results

G. Maconi, A. Friedman, F. Furfaro, 2013 .

Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease

K. Taylor, M. Sparrow, O. Rosella, 2022, Therapeutic drug monitoring.

The role of thiopurine metabolite monitoring in inflammatory bowel disease

M. Sparrow, A. Friedman, L. Beswick, 2014, Expert review of gastroenterology & hepatology.

P614 Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohort

R. Bryant, T. Goodsall, E. Wright, 2023, Journal of Crohn's and Colitis.

Gastroenterologist performed point-of-care gastrointestinal ultrasound improves patient understanding of disease activity, symptomatology, management decisions and clinical outcomes

P. Gibson, A. Friedman, A. Asthana, 2018 .

Use and abuse of faecal occult blood tests in an acute hospital inpatient setting

A. Friedman, G. Hammerschlag, J. Ng, 2010, Internal medicine journal.